ESR1 and breast carcinoma: As depicted in Fig 5, the ERaptD4 showed specific staining in the nuclei of ERα-positive breast cancer cells, where it stained the malignant duct cancer cells without any cross reactivity to fibroblasts, adipocytes, inflammatory cells or the extracellular components.